Company Bioceltix S.A.

Equities

BCX

PLBCLTX00019

Pharmaceuticals

Delayed Warsaw S.E. 03:29:30 2024-06-13 am EDT 5-day change 1st Jan Change
63.1 PLN +4.30% Intraday chart for Bioceltix S.A. +0.16% -29.89%

Business Summary

Bioceltix SA is a Poland-based biopharmaceutical company, which operates in the field of veterinary medicine. The Company deal with the development of candidates for veterinary medicinal products based on the immunomodulatory properties of mesenchymal stem cells used as the active substance of the drug. Entity's products are intended for the treatment of companion animals. The Company carry out research and development works, which enable clinical trials and full registration of medicinal products in the European Medicines Agency, as is the case with medicines and drugs administered to humans.

Number of employees: 28

Managers

Managers TitleAgeSince
Chief Executive Officer 42 18-08-12
Director of Finance/CFO 40 -
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - -
Corporate Officer/Principal 43 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,129,468 2,785,920 ( 67.46 %) 0 67.46 %

Shareholders

NameEquities%Valuation
Kvarko ASI Sp zoo
11.40 %
470,953 11.40 % 8 M zł

Company contact information

Bioceltix SA

Bierutowska 57-59 Strasse

51-317, Wroclaw

+48 71 880 8771

http://www.bioceltix.com
address Bioceltix S.A.(BCX)
  1. Stock Market
  2. Equities
  3. BCX Stock
  4. Company Bioceltix S.A.